Home About Us People Prof. Dr. med. Kirsten Minden
Paediatric Rheumatology
Prof. Dr. med. Kirsten Minden

Paediatric Rheumatology

Prof. Dr. med. Kirsten Minden

German Rheumatism Research Centre
Epidemiology Unit
Charitéplatz 1
10117 Berlin
Phone: +49 (0)30 28460-669 Fax: +49 (0)30 28460-626 minden@drfz.de

Scientific career and Key Publications

Short Biosketch

Kirsten Minden is a paediatric rheumatologist and professor for health services research in rheumatology at the Charité – Universitätsmedizin Berlin, Department of Pediatrics, Respiratory Medicine, Immunology and Critical Care Medicine, and at the German Rheumatism Research Centre (DRFZ).

She trained in Paediatrics and Paediatric Rheumatology at the 2nd Children’s hospital in Berlin-Buch (later: Helios-Klinikum Berlin-Buch). Since 2006, she has been working at the Children’s university hospital of the Charité.

Her areas of interest include childhood arthritis (juvenile idiopathic arthritis, JIA) and other juvenile rheumatic diseases. She has a regular clinic in the Centre for Chronically Sick Children at the Charité Camus Virchow where she sees children and adolescents with arthritis and other rheumatic conditions.

At the DRFZ, she runs a research group that investigates phenotypes, courses, and outcomes of juvenile rheumatic diseases as well as the health care situation of children and young people with rheumatic diseases.

She is the principal investigator of the national paediatric rheumatologic database, the inception cohort of newly diagnosed children with JIA (ICON) and the JIA biologic registry JuMBO.

Kirsten Minden is author/co-author of over 150 pub-med listed publications and a member of several scientific organisations, e.g., the Society for Paediatric Rheumatology (GKJR), the German Society for Rheumatology (DGRh), the German Society for Paediatrics (DGKJ), the Deutsche Rheumaliga, the Paediatric Rheumatology European Society (PReS), the Paediatric Rheumatology INternational Trials Organisation (PRINTO), the German Society for Transitional Medicine (DGfTM). She is, among other activities, the spokesperson of the commission “Health Care and Quality Assurance” of the GKJR and the working group “Transition” of the DGRh and GKJR.

Wissenschaftlicher Werdegang
Seit 2015 Professorin für Versorgungsforschung in der Rheumatologie an der Charité Universitätsmedizin Berlin und am Deutschen Rheuma-Forschungszentrum Berlin
2012 Habilitation
Seit 2001 Wissenschaftlerin am DRFZ, Programmbereich Epidemiologie, seit 2009 Leiterin der Arbeitsgruppe Kinderrheumatologie und Versorgungsforschung
Seit 2006 Kinderrheumatologin im Sozialpädiatrischen Zentrum des Charité Centrums 17 für Frauen-, Kinder- und Jugendmedizin mit Perinatalzentrum und Humangenetik
2003-2006 Oberärztin der Abteilung Kinder- und Jugendrheumatologie des Helios-Klinikums Berlin-Buch
1997-2003 Fachärztin in der Abteilung Kinderrheumatologie des HELIOS-Klinikums Berlin-Buch
1992-1996 Assistenzärztin in der II. Klinik für Kinderheilkunde und Jugendmedizin des Klinikums Berlin-Buch
1990-1992 Ärztin im Praktikum in der II. Klinik für Kinderheilkunde und Jugendmedizin des Klinikums Berlin-Buch
1989 Promotion (Klinik für Orthopädie, Charité Universitätsmedizin Berlin)
1985 Diplom der Medizin (Institut für Anatomie, Charité Universitätsmedizin Berlin)
2006 Additional qualification paediatric rheumatology
2001 Intensive Course in Applied Epidemiology, ARC Epidemiology, University of Manchester, Great Britain
1996 Specialist for paediatrics and adolescent medicine
1992 Approbation
1982-1990 Study of human medicine; Charité University Medicine Berlin
Committee work
Since 2017 Board member of the Initiative für das rheumakranke Kind
Since 2015 Member of the scientific advisory board of the Journal of Rheumatology
Since 2014 Speaker of the working group Transition of the Society for Pediatric Rheumatology
Since 2011 Member of the scientific advisory board of the Journal arthritis+rheuma, from 2011-2019 head of the section paediatric rheumatology
Since 2005 Speaker of the Commission Care and Quality Assurance of the Society for Pediatric Rheumatology
2004-2017 Board member of the Society for Pediatric Rheumatology

• German Network for Healthcare Research (DNVF
• German Society for Rheumatology (DGRh)
• German Society for Pediatric Rheumatology (GKJR)
• Paediatric Rheumatology European Society (PReS)
• German Society for Pediatric and Adolescent Medicine (DGKJ)
• Deutsche Rheuma-Liga

Scientific Awards
2013, 2015 Pfizer Research Prize for Rheumatology
2017 Transition Prize of the Society for Transition Medicine
Selected Publications

Drechsel P, Stüdemann K, Niewerth M, Horneff G, Fischer-Betz R, Seipelt E, Spähtling-Mestekemper S, Aries P, Zink A, Klotsche J, Minden K. Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis – Results from a JIA Biologic Registry. Rheumatology (Oxford). Rheumatology (Oxford). 2020 Mar 1;59(3):603-612.

Minden K, Horneff G, Niewerth M, Seipelt E, Aringer M, Aries P, Foeldvari I, Haas JP, Klein A, Tatsis S, Tenbrock K, Zink A, Klotsche J. The time of DMARD start in Juvenile Idiopathic Arthritis determines the likelihood of a drug-free remission in young adulthood. Arthritis Care Res (Hoboken). 2019 Apr;71(4):471-481.

Foster HE*, Minden K*, Clemente D, Leon L, McDonagh JE, Kamphuis S, Berggren K, van Pelt P, Wouters C, Waite-Jones J, Tattersall R, Wyllie R, Stones SR, Martini A, Constantin T, Schalm S, Fidanci B, Erer B, Dermikaya E, Ozen S, Carmona L. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis. 2017 Apr;76(4):639-646 (*contributed equally).

Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA). Ann Rheum Dis. 2016;75:855-61.

Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K; German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 2007;46:1015-9.

Minden K, Niewerth M, Listing J, Biedermann T, Schöntube M, Zink A. Burden and cost of illness in patients with juvenile idiopathic arthritis. Ann Rheum Dis 2004;63;836-42.

Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schöntube M, Zink A. Long-term outcome in patients with juvenile idiopathic arthritis Arthritis Rheum 2002;46:2392-401.

Minden lab
How can we optimize the care of young people with rheumatism?
Sign up for the
DRFZ NewsFlash